Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Schmidt

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Transplantation|December 1, 1988
Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipientsG M Schmidt, A Kovacs, J A Zaia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasiaM R O'Donnell, G D Long, P M Parker, et al.
Blood|March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsA Nademanee, M R O'Donnell, D S Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cellsA Nademanee, I Sniecinski, G M Schmidt, et al.
Transactions of the Association of American Physicians|January 1, 1979
Bone marrow transplantation as the treatment of choice for "good risk" adult patients with acute leukemiaE Beutler, K G Blume, K J Bross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's diseaseN J Chao, A P Nademanee, G D Long, et al.
Blood|November 1, 1993
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remissionD S Snyder, N J Chao, M D Amylon, et al.
Transplantation Proceedings|March 1, 1981
Bone marrow ablation and marrow transplantation in acute leukemia: influence of clinical pretransplant conditionK G Blume, W E Spruce, S J Forman, et al.
Blood|October 15, 1991
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remissionN J Chao, S J Forman, G M Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Bone marrow transplantation for myelodysplastic and myeloproliferative syndromesM R O'Donnell, A P Nademanee, D S Snyder, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Transplantation|December 1, 1988
Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipientsG M Schmidt, A Kovacs, J A Zaia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasiaM R O'Donnell, G D Long, P M Parker, et al.
Blood|March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsA Nademanee, M R O'Donnell, D S Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cellsA Nademanee, I Sniecinski, G M Schmidt, et al.
Transactions of the Association of American Physicians|January 1, 1979
Bone marrow transplantation as the treatment of choice for "good risk" adult patients with acute leukemiaE Beutler, K G Blume, K J Bross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's diseaseN J Chao, A P Nademanee, G D Long, et al.
Blood|November 1, 1993
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remissionD S Snyder, N J Chao, M D Amylon, et al.
Transplantation Proceedings|March 1, 1981
Bone marrow ablation and marrow transplantation in acute leukemia: influence of clinical pretransplant conditionK G Blume, W E Spruce, S J Forman, et al.
Blood|October 15, 1991
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remissionN J Chao, S J Forman, G M Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Bone marrow transplantation for myelodysplastic and myeloproliferative syndromesM R O'Donnell, A P Nademanee, D S Snyder, et al.
Pageof 9